Published in Med Clin (Barc) on October 31, 1992
Cigarette smoking as a risk factor for tuberculosis in young adults: a case-control study. Tuber Lung Dis (1996) 2.62
[Efficiency of prevaccination screening of anti-HBc in the anti-hepatitis B vaccination programs]. Med Clin (Barc) (1992) 1.94
Clinical and epidemiological aspects of smoking and tuberculosis: a study of 13,038 cases. Int J Tuberc Lung Dis (2005) 1.49
Giant molluscum contagiosum in AIDS. Int J Dermatol (1996) 1.39
[Prevalence of hepatitis C virus antibodies in homosexual men]. Med Clin (Barc) (1994) 1.39
[Retrospective evaluation of the effectiveness of the BCG vaccine campaign in newborns of Barcelona]. Med Clin (Barc) (1992) 1.39
[Screening for excessive alcohol consumption]. Med Clin (Barc) (1994) 1.38
[Susceptibility to measles, rubella and parotitis in young adults]. Med Clin (Barc) (1996) 1.38
[Excess length of stay attributable to nosocomial bacteremia: usefulness of the Hospitalization Appropriateness Protocol]. Med Clin (Barc) (1999) 1.38
Passive smoking and risk of pulmonary tuberculosis in children immediately following infection. A case-control study. Tuber Lung Dis (1996) 1.32
Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis (2006) 1.23
Hepatitis A and B in children and adolescents--what can we learn from Puglia (Italy) and Catalonia (Spain)? Vaccine (2000) 1.12
Seroepidemiology of HIV-1 infection in a Catalonian penitentiary. AIDS (1990) 1.11
Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR. Eur J Clin Microbiol Infect Dis (2011) 1.11
A community outbreak of Legionnaires' disease: evidence of a cooling tower as the source. Clin Microbiol Infect (2006) 1.07
Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly. Eur Respir J (2010) 1.06
Longitudinal study of plasma lipids and lipoprotein cholesterol in normal pregnancy and puerperium. Gynecol Obstet Invest (1988) 1.03
Vaccination coverage in indigenous and immigrant children under 3 years of age in Catalonia (Spain). Vaccine (2007) 0.99
Community-based seroepidemiological survey of HCV infection in Catalonia, Spain. J Med Virol (2001) 0.99
Influence of treatment with zidovudine (ZDV) on the long-term survival of AIDS patients. J Acquir Immune Defic Syndr (1992) 0.97
Immunogenicity and reactogenicity of the adult tetanus-diphtheria vaccine. How many doses are necessary? Epidemiol Infect (2001) 0.96
Prevalence of Neisseria meningitidis carriers in the school population of Catalonia, Spain. Epidemiol Infect (2001) 0.93
Timeliness of notification in infectious disease cases. Public Health Rep (1992) 0.92
Prevalence of Haemophilus influenzae pharyngeal carriers in the school population of Catalonia. Working Group on invasive disease caused by Haemophilus influenzae. Eur J Epidemiol (2000) 0.92
[Changes in seroepidemiology of hepatitis A virus infection in Catalonia in the period 1989-1996. Implications for new vaccination strategy]. Med Clin (Barc) (1999) 0.91
The epidemiology of invasive Streptococcus pneumoniae disease in Catalonia (Spain). A hospital-based study. Vaccine (2002) 0.91
Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction. Vaccine (2008) 0.91
Evaluation of the smoke-free Olympics project. Promot Educ (1994) 0.91
Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study. Diabetes Res Clin Pract (1999) 0.91
Artefacts in oral incisional biopsies in general dental practice: a pathology audit. Oral Dis (2004) 0.90
Near-infrared libraries in the pharmaceutical industry: a solution for identity confirmation. Analyst (2001) 0.90
Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes. Vaccine (2000) 0.90
East-west differences in reported preventive practices. A comparative study of six European areas of the WHO-CINDI programme. Eur J Public Health (2001) 0.90
Infant mortality, per capita income, and adult illiteracy: an ecological approach. Am J Public Health (1992) 0.89
Changes in diet and mortality from selected cancers in southern Mediterranean countries, 1960-1989. Eur J Clin Nutr (1993) 0.88
Changing patterns of fat consumption in Spain. Eur J Clin Nutr (1993) 0.87
Community outbreak of acute respiratory infection by Mycoplasma pneumoniae. Eur J Epidemiol (1996) 0.87
Contacts with children and young people and adult risk of suffering herpes zoster. Vaccine (2011) 0.87
Epidemiology of cardiovascular disease risk factors in Catalonia (Spain). Eur J Epidemiol (1993) 0.86
Review of the utilisation of a university hospital in Barcelona (Spain): evolution 1992-1996. Eur J Epidemiol (2001) 0.86
Artefacts produced by suture traction during incisional biopsy of oral lesions. Clin Otolaryngol Allied Sci (2002) 0.86
[Anti-tobacco counseling]. Med Clin (Barc) (1994) 0.86
Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination. Vaccine (2007) 0.85
Inclusion of laboratory test results in the surveillance of infectious diseases. Int J Epidemiol (1991) 0.84
Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination. Epidemiol Infect (2011) 0.84
Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain. Public Health Rep (1995) 0.84
Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools. Vaccine (2005) 0.83
Expression of heat shock protein (HSP70) in oral lichen planus and non-dysplastic oral leucoplakia. Clin Otolaryngol Allied Sci (2004) 0.83
Cross-sectional growth study of the child and adolescent population of Catalonia (Spain). Ann Hum Biol (1997) 0.82
Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults. Vaccine (1996) 0.82
Cost-effectiveness of breast cancer screening in Spain. Int J Technol Assess Health Care (1996) 0.82
Importance of sexual transmission of hepatitis C virus in seropositive pregnant women: a case-control study. J Med Virol (1997) 0.82
Smoking prevalence decreases in males but not in females: the case of Catalonia (Spain) Eur J Epidemiol (1998) 0.81
[Prevalence and factors associated to the presence of fatty liver in apparently healthy adult men]. Med Clin (Barc) (2000) 0.81
Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain. J Viral Hepat (2008) 0.81
Measles epidemiology in Catalonia (Spain): implications for a regional vaccination programme. Int J Epidemiol (1999) 0.81
Relationship between severity, costs and claims of hospitalized patients using the Severity of Illness Index. Eur J Epidemiol (1994) 0.81
Visualization of axonally transported horseradish peroxidase using enhanced immunocytochemical detection: a direct comparison with the tetramethylbenzidine method. J Histochem Cytochem (1999) 0.81
A comparison of five questionnaires to assess alcohol consumption in a Mediterranean population. Public Health Nutr (2002) 0.81
An outbreak of food poisoning due to a genogroup I norovirus. Epidemiol Infect (2005) 0.81
[The vaccination of medical and nursing students against hepatitis B]. Med Clin (Barc) (1993) 0.80
[Smoking prevalence trends in Catalonia, Spain, 1982-1994]. Med Clin (Barc) (1997) 0.80
Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age. BJOG (2007) 0.80
Assessment of dental students' diagnostic accuracy for oral cancer screening. J Dent Educ (1997) 0.80
Estimated varicella incidence on the basis of a seroprevalence survey. Epidemiol Infect (2001) 0.79
Cost-effectiveness of rifampin for 4 months and isoniazid for 9 months in the treatment of tuberculosis infection. Eur J Clin Microbiol Infect Dis (2012) 0.79
[Epidemiology of obesity among the adult population of Catalonia]. An Med Interna (1992) 0.79
In vitro evaluation of newly synthesised [1,2,4]triazolo[1,5a]pyrimidine derivatives against Trypanosoma cruzi, Leishmania donovani and Phytomonas staheli. Comp Biochem Physiol C Toxicol Pharmacol (2000) 0.79
Incidence of type 1 (insulin-dependent) diabetes mellitus in Catalonia, Spain. The Catalan Epidemiology Diabetes Study Group. Diabetologia (1992) 0.79
Effects of tramadol and dexketoprofen on analgesia and gastrointestinal transit in mice. Fundam Clin Pharmacol (2009) 0.79
Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives. Vaccine (2007) 0.79
[Malaria. Analysis of 149 cases (1981-1987)]. Enferm Infecc Microbiol Clin (1990) 0.79
[Detection of cardiovascular risk factors in the reformed primary care network in Catalonia. Comparison between the years 1995 and 2000]. Aten Primaria (2003) 0.79
[A community outbreak of Legionnaires' disease in Barcelona: epidemiologic and environmental study]. Med Clin (Barc) (1989) 0.78
[Adult vaccinations]. Med Clin (Barc) (1994) 0.78
Economic evaluation of community programs for the prevention of dental caries in Catalonia, Spain. Community Dent Oral Epidemiol (1987) 0.78
Determinants of the nutritional status of vitamin E in a non-smoking Mediterranean population. Analysis of the effect of vitamin E intake, alcohol consumption and body mass index on the serum alpha-tocopherol concentration. Eur J Clin Nutr (1997) 0.78
[The decline of tuberculosis infection in schoolchildren of Barcelona]. Med Clin (Barc) (1988) 0.78
Measles immunity and vaccination policy in Catalonia. Vaccine (1999) 0.78